Response to Kibe Y et al. "Methodological concerns for investigating the effects of midtreatment break of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC)". (June 2020) - Jackson, W.C.; Cuneo, K.C.; Lawrence, T.S.; Schipper, M.J.; Owen, D.